Thyroglobulin autoantibodies in endocrine diseases

Area of Science:

• Endocrinology
• Immunology
• Clinical Chemistry

Background:

• Thyroglobulin autoantibodies (Tgl-AAb) are key biomarkers in autoimmune thyroid diseases.
• Accurate and efficient measurement of Tgl-AAb is crucial for diagnosis and management.
• Existing methods may have limitations in speed or accessibility.

Purpose of the Study:

• To develop and validate a simple, rapid haemagglutination kit for measuring Tgl-AAb.
• To assess the prevalence and titres of Tgl-AAb in a large cohort of endocrine patients, particularly those with thyroid disorders.
• To analyze the correlation between Tgl-AAb levels and endocrine/thyroid pathology.

Main Methods:

• Development of a novel haemagglutination laboratory kit for Tgl-AAb measurement.
• Application of the kit to analyze sera from 2861 endocrine patients and 700 blood donors.
• Classification and analysis of Tgl-AAb positive and negative sera based on endocrine pathology, especially thyroid disorders.
• Grouping of positive thyroid disease cases by Tgl-AAb titre levels and Tgl-precipitin results.

Main Results:

• The Tgl-AAb kit demonstrated effectiveness in measuring antibody titres.
• Prevalence of Tgl-AAb positive sera was 11.6% in endocrine patients (low titre <1:200), nearly double that of blood donors (6.4%).
• Among patients with significant titres (>1:200), 30.47% showed titres between 1:200-1:5000.

Conclusions:

• The developed haemagglutination kit provides a simple and rapid method for Tgl-AAb measurement.
• Elevated Tgl-AAb prevalence in endocrine patients, particularly those with thyroid disorders, highlights the utility of this marker.
• The study discusses potential discrepancies and future directions for laboratory investigation of thyroid autoimmune diseases, proposing an immunogram strategy.